We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life
EffRx Obtains Swiss Marketing Authorization for Alkindi® for Paediatric Adrenocortical Insufficiency
The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.
Partnering with Us
Our strategy relies on partnerships for shared commercial success. We welcome you to find out more about partnering.